The objective of this study is to provide a comprehensive and systematic understanding of the significance of CPZ expression in gastric cancer and its immunoregulatory effects, thereby offering new perspectives and theoretical foundations for identifying molecular biomarkers for gastric cancer diagnosis, developing novel therapeutic targets, and optimizing clinical treatment strategies. This evidence concerns the gene CPZ and gastric cancer.